Last update 20 Mar 2025

Defibrase

Overview

Basic Info

Drug Type
Chemical drugs, Enzyme
Synonyms
注射用降纤酶
Target
Fibrinogen
Action
inhibitors
Mechanism
Fibrinogen inhibitors
Therapeutic Areas
Nervous System DiseasesCardiovascular DiseasesOtorhinolaryngologic Diseases+ [2]
Active Indication
Angina, UnstableBrain InfarctionHearing Loss, Sudden+ [6]
Inactive Indication-
Originator Organization
Kunming Longjin Pharmaceutical Co., Ltd.Kunming Longjin Pharmaceutical Co., Ltd.
Active Organization
Kunming Longjin Pharmaceutical Co., Ltd.Kunming Longjin Pharmaceutical Co., Ltd.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
China (01 Jan 1998),
Angina, UnstableBrain InfarctionHearing Loss, Sudden+ [6]
Regulation-
Login to view timeline

Related

100 Clinical Results associated with Defibrase
Login to view more data
100 Translational Medicine associated with Defibrase
Login to view more data
100 Patents (Medical) associated with Defibrase
Login to view more data
1
Literatures (Medical) associated with Defibrase
01 Jan 1982Bulletin des societes d'ophtalmologie de France
[Medical treatment of retinal venous occlusions with a new defibrinating agent (Defibrase). Preliminary study].
100 Deals associated with Defibrase
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Angina, Unstable
China
Kunming Longjin Pharmaceutical Co., Ltd.Kunming Longjin Pharmaceutical Co., Ltd.
01 Jan 1998
Brain Infarction
China
Kunming Longjin Pharmaceutical Co., Ltd.Kunming Longjin Pharmaceutical Co., Ltd.
01 Jan 1998
Hearing Loss, Sudden
China
Kunming Longjin Pharmaceutical Co., Ltd.Kunming Longjin Pharmaceutical Co., Ltd.
01 Jan 1998
Ischaemic cerebral infarction
China
Kunming Longjin Pharmaceutical Co., Ltd.Kunming Longjin Pharmaceutical Co., Ltd.
01 Jan 1998
Ischemic Attack, Transient
China
Kunming Longjin Pharmaceutical Co., Ltd.Kunming Longjin Pharmaceutical Co., Ltd.
01 Jan 1998
Myocardial Infarction
China
Kunming Longjin Pharmaceutical Co., Ltd.Kunming Longjin Pharmaceutical Co., Ltd.
01 Jan 1998
Pulmonary Embolism
China
Kunming Longjin Pharmaceutical Co., Ltd.Kunming Longjin Pharmaceutical Co., Ltd.
01 Jan 1998
Raynaud Disease
China
Kunming Longjin Pharmaceutical Co., Ltd.Kunming Longjin Pharmaceutical Co., Ltd.
01 Jan 1998
Thromboangiitis Obliterans
China
Kunming Longjin Pharmaceutical Co., Ltd.Kunming Longjin Pharmaceutical Co., Ltd.
01 Jan 1998
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free